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Abstract
Background: The co-administration of multiple drugs (polypharmacy) is the single most common cause of adverse
drug events in the older population, and residents of long-term care facilities (LTCFs) are at particularly high risk of
medication harm. ‘Deprescribing’ – the withdrawal of an inappropriate medication with goal of managing
polypharmacy and improving outcomes – may improve the quality of life of LTCF residents. The RELEASE study
sought to explore perceptions of medication use and the concept of deprescribing in LTCFs.
Methods: Focus groups and interviews were conducted with General Practitioners (GPs), pharmacists, nursing staff,
residents and their relatives within three LTCFs in the Illawarra-Shoalhaven region of NSW, Australia. Audiotapes
were transcribed verbatim and, using the Integrative Model of Behaviour Prediction as a framework, thematic
analysis of transcripts was conducted using QSR NVivo 10.
Results: Participants acknowledged the burden of too many medications (time to administer, physical discomfort,
cost), yet displayed passivity towards medication reduction. Residents and relatives lacked understanding of
medicine indications or potential harms. Willingness to initiate and accept medication change was dependent on
the GP, who emerged as a central trusted figure. GPs preferred ‘the path of least resistance’, signalling systems
barriers (poor uniformity of LTCF medical records, limited trained LTCF personnel); time constraints (resident
consultations, follow-up with specialists and family); and the organisation of care (collaborating with LTCF staff,
pharmacists and prescribing specialists) as obstacles to deprescribing.
Conclusions: Targeted engagement is required to raise awareness of the risks of polypharmacy in LTCFs and
encourage acceptance of deprescribing amongst residents and their relatives. GPs are integral to the success of
deprescribing initiatives within this sector.
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Background
Older people in Australia accumulate large numbers of
different medications, often prescribed by a number of
specialists as well as the General Practitioner (GP). A
cross-sectional survey of 4500 community-dwelling Aus-
tralians found that almost 50 % of respondents aged
65 years and older reported taking five or more medi-
cines, and more than 10 % reported using 10 or more
[1]. For residents of long-term care facilities (LTCFs), a
frail population with often complex health conditions,
the average number of prescribed medications is signifi-
cantly higher than their community-dwelling counter-
parts [2, 3]. Studies in the long-term care setting report
polypharmacy (defined as the concomitant use of five or
more medicines) in up to 95 % of residents, with an
average of 7–10 medications per resident [3–5].
The use of greater numbers of medications has been
independently associated with an increased risk of ad-
verse drug events in both community-dwelling [6] and
institutionalised [7] older persons, as well as an in-
creased risk of hospital admission [8]. A review of Aus-
tralian adverse drug event data [9] identified that more
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than 30 % of unplanned hospital admissions for people
over 75 years of age were medication related. For
residents of LTCFs, adverse drug reactions are common
[7, 10, 11] and resulting hospital admissions often lend
greater complexity to a resident’s medication regimen
[12, 13]. While admission to hospital might provide an
opportunity for medication review, analysis of over 200
patients aged 70 years and older discharged from acute
care hospitals to LTCFs in Brisbane and Melbourne,
Australia, showed that the proportion of these patients
taking four or more potentially inappropriate medicines
(PIMs) actually increased from 0.5 % on admission to
2.9 % on discharge [12].
Deprescribing – the process of withdrawal of an in-
appropriate medication supervised by a health care pro-
fessional with the goal of managing polypharmacy and
improving outcomes [14] – is a health care innovation
with a real potential to relieve unnecessary medication-
related suffering and disability in vulnerable older popu-
lations [15]. In the long-term care setting, efficacious
deprescribing may not only have a positive impact on
residents’ physical and social functioning, but also make
available valuable resources for the provision of timely
and appropriate care addressing the physical, spiritual,
social and cultural needs of each resident [16]. A num-
ber of tools exist to assist practitioners in deprescribing
decisions [17–22], and feasibility studies in both
community-dwelling [23–25] and facility-based [26, 27]
adults have suggested that the concept is acceptable to
patients and recruitment feasible. While clinical trials of
the safety and efficacy of medication withdrawal in the
older population remain in their infancy, studies to-date
have demonstrated both short-term physical and cogni-
tive benefits, and no significant harm, following reduc-
tion of antihypertensives, benzodiazepine, psychotropic
agents and statins [28, 29].
While the impact of deprescribing will depend on both
the clinical implications and patient acceptance of medi-
cation withdrawal, few studies have implemented quali-
tative methods to explore perception of medication use
and discontinuation held by either patient or health pro-
fessional [25, 30]. Further, institutionalised persons such
as hospital inpatients and residents of LTCFs have up to
now been largely omitted from research in this field.
Common barriers and enablers influencing a decision to
cease a medication have been reported by community-
based patients of varying ages [31]. These include a per-
ceived benefit of medicine continuation, the time and
physician support required during the process of depre-
scribing, the influence (both positive and negative) of
family and health professionals, and a fear of adverse ef-
fects from medicine cessation.
The RELEASE study – Deprescribing: A new afford-
able health care model for the prescribing and
administration of medications for vulnerable older people
in aged care homes – is a qualitative study undertaken
to explore a range of key stakeholder perspectives on
medication use and the concept of deprescribing in the
Australian long-term care sector. RELEASE aims to im-
prove our understanding of the attitudes towards medi-
cation reduction held by the frail elderly in residential
care – a population group taking more medications than
any other, yet who have been underrepresented in stud-
ies of deprescribing to-date. This paper reports percep-
tions of medication use and the concept of deprescribing
for LTCF residents, as identified by the RELEASE study
participants. The application of these findings to inform-
ing the development of deprescribing initiatives within
the aged care sector is discussed.
Methods
We conducted focus groups with GPs, staff members,
residents and their relatives within LTCFs in the
Illawarra-Shoalhaven region of New South Wales. Semi-
structured interviews with pharmacists, all providing
pharmaceutical dispensing or review services to LTCFs
within the same region, were also undertaken by a mem-
ber of the research team.
Participating GPs were recruited by newsletter an-
nouncements and email invitation distributed by the
Illawarra-Shoalhaven Medicare Local – a local, not-for-
profit organisation supporting the primary health sector.
The Director of Nursing at each collaborating LTCF ini-
tially nominated residents considered able to provide in-
formed consent and participate in focus group
discussions, and these individuals were then approached
separately by the study Geriatrician who assessed cogni-
tive and communicative capacity. Only those residents
with mental capacity to understand the study were in-
vited to take part. LTCF staff and relatives of residents
were invited to take part in the study’s focus groups by
notices placed in common areas of the facilities and dir-
ect invitation from the facility manager. Two participat-
ing pharmacists were approached directly by a member
of the research team and snowball sampling [32] used to
recruit additional pharmacists. All participants provided
informed written or oral consent.
Focus groups with residents, their relatives and LTCF
staff were conducted on site at each collaborating LTCF
to ensure that participants were in a comfortable envir-
onment to facilitate an open discussion. The GP focus
group was held at a breakfast meeting at the Medicare
Local headquarters. Discussion guides unique to each
participant group were developed based on the frame-
work of the Integrative Model of Behaviour Prediction
(IMBP) [33] (Fig. 1) and used to prompt dialogue
according to the model’s key constructs. The IMBP is a
theoretical model used widely in health behaviour
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research which predicts that people act on their inten-
tions when they have the necessary skills and when en-
vironmental factors do not impede behavioural
performance [34]. Our discussion guide topics included
current behavioural practices and normative beliefs re-
garding prescription medication use by older LTCF
residents; understanding of and attitudes towards depre-
scribing; external factors influencing medication behav-
iour; and potential approaches to a deprescribing
strategy within the aged care sector (Additional file 1).
Each focus group was conducted in English and led by a
moderator with a health research background and ex-
perience as an interviewer and group facilitator (LK/AP),
with one observer and note taker (JH). A summary of
the discussion was read back to participants at the com-
pletion of each focus group in order to confirm the in-
terpretations of the participants’ responses made by the
moderator. These focus groups were audiotaped and
lasted approximately one hour. Basic demographic de-
tails of focus group participants were elicited by a short,
interview-based questionnaire.
Semi-structured interviews with pharmacists were
conducted via telephone and aided by an interview guide
also developed using the framework of the IMBP
(Additional file 1). An overview of the professional ex-
perience of participating pharmacists was obtained. All
interviews were audiotaped.
Ethics approval for the RELEASE study was granted by
the University of Sydney Human Research Ethics Com-
mittee (Project No. 2013/1076). Data collection was car-
ried out between January and October 2014.
Data analysis
Focus group audiotapes were transcribed verbatim and
the transcript checked for accuracy by a member of the
research team. Using QSR NVivo 10 (QSR International,
Burlington, MA, USA), transcripts were then separately
coded by two members of the research team and codes
reviewed, refined and sorted into a single coding frame-
work based on main categories of discussion. Emerging
themes were explored by all members of the research
team in relation to the framework of the IMBP, focusing
on the constructs of attitudes, norms, self-efficacy, envir-
onmental factors, intent, and skills and abilities. The re-
search team worked collaboratively to further refine




Nine focus groups were conducted with residents (n =
25), relatives (n = 16) and LTCF staff members (n = 19)
from three LTCFs in the Illawarra-Shoalhaven area
(Facility [F] A, B and C), prior to achieving data satur-
ation. A tenth focus group was held with 8 GPs, all of
who provided regular medical care to residents of LTCFs
within the study region. Four pharmacists – two dis-
pensing pharmacists and two accredited medication re-
view pharmacists – completed semi-structured
interviews.
A summary of focus group participants is provided in
Table 1.
Perceptions of medication use and deprescribing
Although participant discussions were prompted to
address all constructs of the IMBP framework, themes
emerging from the analysis were most clearly associ-
ated with five key elements: environmental factors,
attitudes, control beliefs and self-efficacy, and skills
Fig. 1 An Integrative Model of Behaviour Prediction, adapted from Fishbein (2006). Themes emerging from the analysis were most clearly
associated with five key elements: environmental factors, attitudes, control beliefs and self-efficacy, and skills and abilities
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and abilities (Fig. 1). These are reported here and ex-
panded in Fig. 2.
Environmental factors
Environmental factors were noted most frequently by all
participant groups as influencing behaviours relating to
medication use and medication management. These en-
vironmental influences included LTCF organisational
systems (communication, medical record technology, co-
ordination of a resident’s medical care), LTCF policies,
the availability and scheduling of staff, staff workload
burden, and coordinating the role of the various health
care providers.
The pitfalls of coordinated care It was noted that
most frail older residents have a number of specialist
healthcare providers in addition to their GP, and that
inadequate communication between providers can
cause inefficiencies in medication management. Some
LTCF residents recounted having been prescribed
medication for either an acute or circumstance-
related condition in the past, e.g. an antibiotic, anti-
histamine, antidepressant, and, due to lack of review,
this medication then being continued in their medica-
tion regime for months after the condition had
subsided.
“…so the psycho-geriatrician can come in and pre-
scribe all these things and you come in two weeks
later… you think, oh, I didn’t start that.” [GP6; male,
43 years]
“I’ve been taking Phenergan tablets for an itch. I have
been on them two or three months, and I am taking
three a day, and I don’t know what for. But I am still
taking it.” [Resident FA; female, 86 years]
The role of hospital admissions, both prior to a resi-
dent’s initial LTCF admission and during their stay, was
highlighted by both LTCF staff and pharmacists as a
significant contributor to medication accrual. Partici-
pants described how residents often amassed large num-
bers of new medications during hospital admission,
prescribed according to hospital protocol. Following dis-
charge back to the LTCF, residents then failed to
undergo timely review of these new medications by their
GP. One of the pharmacists expressed their concern,
saying:
“Often enough there's an intermediary system that
plays a massive part in why they're on so much
[medication]. It's a hospital… That's where the masses
of medication get started and GPs, I feel, feel
compelled to continue some of those medications.”
[Dispensing Pharmacist]
Negotiating a complex system The organisation of a
resident’s care within the LTCF emerged as an influential
factor in medication management decisions. GPs in
particular expressed frustration with communications
arising from the LTCF, describing them as ‘relentless’
and ‘a never ending stream’, and were subsequently re-
luctant to engage in activity (such as ongoing medication
Table 1 Summary of participants of the RELEASE Study focus groups
Facility A (96 residents) Facility B (108 residents) Facility C (100 residents)
Residents (n) 13 7 5
Age (mean, range), years 89 (76–100) 84 (75–93) 90 (83–99)
Female % 100 71 60
Length of time in LTCF (range), years 1 − 13 1 − 9 1 − 3
Number medications daily (median, range) 8 (5–20) 9 (2–17) 5 (5–10)
Relatives (n) 5 7 4
Age (mean, range), years 63 (55–71) 70 (54–84) 63 (55–72)
Female % 40 83 75
LTCF staff (n) 8 7 4
Age (mean, range), years 45 (21–69) 40 (27–54) 51 (44–56)
Time working in aged care (range), years 1 − 15 3 − 20 2.5 − 8
General Practitioners (n) 8
Age (mean, range), years 56 (43–73)
Experience as GP (range), years 20 − 42
Total LTCFs serviced (range) 1 − 6
Total LTCF patients (range) 10 − 150
GP general practitioner, LTCF long-term care facility
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refinement) that would inevitably require additional co-
ordination with the LTCF.
“I think negotiating with the nursing home to get
things done is extremely frustrating, and I think that’s
a big barrier for us to be able to get other doctors to
actually provide services there.” [GP6; male, 43 years]
An absence of standard medical charts within and
across LTCFs also vexed GPs, adding to their perceived
complexities of initiating medication change. A number
of GPs expressed their preference for electronic medical
records and the ability to use their practice software for
their LTCF patient records.
“When anybody comes and writes anything, they just
squash out one and write underneath it and it ends
up becoming like a dogs dinner… That drives me mad.
So lack of uniformity of medication documentation is
a barrier.” [GP3; female, 51 years]
The present frequency and structure of resident
medication reviews, conducted as part of the compul-
sory biennial LTCF Residential Medication Manage-
ment Review (RMMR) program and at other times on
request of the GP, was questioned by some partici-
pants. Pharmacists and relatives expressed concern
that the current compulsory two year RMMR schedule is
far too long.
Fig. 2 Major themes (in bold) and intermediate coding framework (boxed) emerging from discussions about medication use and deprescribing
in long-term care facilities with participants of the RELEASE study. GP general practitioner, f female, F facility, LTCF long-term care facility, m male,
RN registered nurse, y years
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“Two years is not good enough really, to be honest with
you, because as you know it’s an aged care facility and
there’re a lot of things that go on in two years that
need to get addressed in regard to medication.”
[Dispensing Pharmacist]
Medication reviews conducted under the RMMR pro-
gram did not involve face-to-face assessment of individ-
ual residents but instead relied on a review of
medication charts and resident notes. GPs stated that
they were more likely to apply the recommendations of
a medication review that was conducted by a local
pharmacist with resident contact, rather than the auto-
mated RMMR report.
“And do you have any personal interaction with the
resident during the review process?” [Facilitator] “See,
that’s the thing – not really, no… It’s always relied on
staff notes, staff reports and all that they’re seeing in
behaviour… and yeah, that’s the way it’s done.”
[Review Pharmacist]
“I’d just rather someone like Pharmacist X or
Pharmacist Y, or someone whose opinion we actually
really respect [conduct the medication review]. When
they do them they’re high quality and actually useful
for the patient – rather than just having it stitched up
by this cynical document which is computer
generated.” [GP2; male, 58 years]
Strain on resources Time restraints and a shortage of
health professionals willing to engage with aged care
were cited by both LTCF staff and GPs as major obsta-
cles to the implementation of GP-led medication reviews
and consequential deprescribing strategies for individual
residents. All participating GPs provided care to LTCF
residents on a part time basis and experienced difficul-
ties in balancing routine visits to the LTCF, responding
to LTCF emergency requests and following up with a
resident’s medical specialists and family, with their regu-
lar practice workload. The acknowledged additional time
required to implement a strategic approach to depre-
scribing was a critical impediment to their willingness to
engage in such a process. In Australia, GPs do not have
a fixed practice list and difficulties in successfully pro-
moting aged care amongst younger GPs meant that the
bulk of the workload fell on the more senior GPs who
had been engaged in LTCF visits for years.
“All of our doctors are essentially part-time… And the
challenge of the part-time GP workforce in covering
nursing homes, providing on call services, is something
that we have never managed to sort out, but have
always hoped to.” [GP3; female, 51 years]
“It’s a great idea to reduce medication if you can do it
in a safe manner that’s not going to make us have to
go out to the nursing home 55 more times.”
[GP5; male, 67 years]
The shortage of registered nurses (RN) rostered for each
LTCF shift and the high task-load of carers was a concern
raised by family members, who felt that there was inad-
equate time available for LTCF staff to conduct the obser-
vation necessary to identify any medication-related issues
of their relative. Some carers described spending “most of
their shift” conducting medication rounds, and an average
time of 2 h for each of the three daily medication rounds
was experienced across all participating LTCFs.
“I don’t think they’ve got time to observe whether
there’s a change needed or they [medications] should
be reviewed.” [Relative FC; female, 72 years]
Skills and abilities
All participants questioned either their own or others’
knowledge of an older person’s medication requirements
and ability to initiate indicated changes to a resident’s
medication regimen.
Medication knowledge among residents and relatives
A lack of knowledge of medicine indications, actions and
potential adverse events was evident in both LTCF resi-
dents and their relatives. This appeared to contribute to a
general apathy towards polypharmacy and the concept of
PIMs from both groups. While the majority of residents
were aware of the number of pills they were required to
take each day, they had little idea of the indication for in-
dividual medicines. Relatives held a similarly limited un-
derstanding – many described keeping track of medicine
names and numbers through pharmacy invoices but again
were unfamiliar with the specific medical indication for
which each medication had been prescribed.
Both residents and relatives were able to identify only
few medication side effects – ‘dry mouth’ and ‘drowsi-
ness’ being the most common. Those with prior experi-
ence of a medication-related incident had some wider
adverse event knowledge, including warfarin-related
bleeding and dizziness. Overall, however, there was min-
imal recognition of medication-related adverse drug re-
actions, including the well-established increased risk of
falls and impaired physical and cognitive function.
“I take so many tiny little ones. And what they are for,
I don’t know.” [Resident FA; female, 71 years]
“I don’t know what the negatives [medication side
effects] would be, but sometimes they just flush
through your body. They’re not really essential if you
don’t physically work.” [Relative FB; female, 71 years]
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GP confidence to deprescribe GPs varied in their con-
fidence to make informed decisions about medication
reduction and cessation. Medicines for Alzheimer’s dis-
ease, dementia and Parkinson’s disease posed particular
uncertainty for GPs when considering a deprescribing
strategy. GPs noted the absence of any protocol for
deprescribing and agreed that standard protocols of
medication management across LTCFs could facilitate
co-ordinated medical decision making by all persons
providing care to the resident.
“I’m not confident about other medications though…
Say someone was Parkinsonism drugs – I would be less
confident stopping it because I do initiate anti-
Parkinsonism drugs, but not at the higher end of
them.” [GP7; male, 52 years]
“If there was some protocol-driven way [to
deprescribe]… for example, teleconferencing with a
geriatrician every time someone is admitted to a
nursing home, something like that, to set up [a
resident’s medication] protocol. Something that
doesn’t really involve us as much.
[GP3; female, 51 years]
Lack of skilled personnel on the ground A number of
GPs complained about the skill deficiency of LTCF nurs-
ing staff, which they believed added unnecessarily to
their burden of responsibility as well as complicating
medical care processes. Pharmacists also commented on
the need for the further education of nursing staff and
carers, particularly in relation to medication side effects
and their documentation and management. For one GP,
the perceived higher level if skills displayed by a small
number of nursing staff was the only thing keeping them
engaged in the aged care sector.
“… most [nursing staff] are very under skilled, very
unintelligent, and not able to make any decisions for
themselves.” [GP; female, 59 years]
“It’s a matter of educating them [nursing staff] to
understand that they don’t need to know the
medicines… they don’t need to know specific details,
they need to provide information about that resident
that’s documented well and correctly so that we can
use that information.” [Review Pharmacist]
Control beliefs & self-efficacy
Participants perceived varying external factors as
restricting their ability to query, initiate or manage
medication-related issues, and expressed limited belief in
their own capabilities to independently instigate medica-
tion change. Together these factors appear to have
created apathy, absence of accountability, and lack of
confidence to initiate strategies of medication reduction
for LTCF residents in this setting.
Whatever the GP says goes The basis of the apathy to-
wards medication use displayed by LTCF residents and
relatives appeared to rest in their complete trust in the
care and decisions of the GP. Participating LTCF resi-
dents, relatives, staff and pharmacists placed the GP as
the pivotal entity in a resident’s prescribing decisions
and ongoing medication management, and as holding
the key to the success of any potential deprescribing
strategy. While a number of LTCF staff questioned some
GPs’ motivation and self-efficacy towards initiating
medication review and modification, the overwhelming
belief from residents and their relatives was that a GP’s
management is not to be questioned. Present LTCF pol-
icies and procedures governing the process for a resi-
dent’s medicines decisions, where medication-related
queries are escalated from carer to RN to GP reinforce
the significance of the role of the GP.
“The doctor has got the training and the knowledge so
we have to go with their recommendation.” [Relative
FA; female, 67 years]
No one wants to be the one who flicks the switch A
medico-legal angle on deprescribing was broached by
both GPs and pharmacists. GPs discussed exercising
caution with initiating medication changes, particularly
where they assumed a resident’s family had strong ex-
pectations of medicines keeping their relative alive. This
perceived pressure from relatives served as a barrier to
ceasing or reducing certain drug classes. GPs were also
cautious with the documented recommendations of
non-commissioned medication reviews – expressing
concern about the legal risks of not implementing re-
view recommendations. The participating review phar-
macists had both experienced the averseness of GPs
towards non-commissioned reviews but dismissed their
legal concerns, confirming that the medication review
report was not a legally binding document.
“It’s [medication review report] one of those pieces of
paper which goes in the shredder for me, if I haven’t
got the time to negotiate or to really think about it.
Because medico-legally it’s a document which actually
stitches you up.” [GP6; male, 43 years]
Attitudes
If it ain’t broke, don’t fix it While the total numbers of
daily medications for an individual resident was often
viewed as excessive by both the resident and relatives,
and the physical discomfort of taking medicines a source
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of frequent complaints, neither group were self-
motivated to query and modify current medicines. By
habitually placing their trust in the decisions of the GP,
residents and relatives had minimal experience in dis-
cussing medications issues or questioning prescribing
decisions. A number of residents expressed fear at the
concept of reducing or ceasing some of their current
medications, believing that their medicines were
prolonging their life.
“They’d [the GP] have to convince me that it was the
right thing to do before I would agree to it.” [Relative
FB; female, 69 years]
“That’s the only way I’m still walking on two legs. If I
didn’t have it [medication] I’d be probably already six
foot under the ground.” [Resident FC; male, 83 years]
The (not so) bright lights of aged care Participating
GPs described the general perception among their pro-
fession of LTCF work being time-consuming and frus-
trating, and having negative financial impact on practice
profits. Under current arrangements, GPs are reim-
bursed for LTCF consultations via the Government’s
Medicare Benefits Schedule, within which per-patient re-
imbursement is lower when multiple consultations are
conducted during a single visit, and there is no compen-
sation for travel time and clinically relevant tasks re-
quired post visit. GP participants believed that these
factors contributed to the overall disinterest in working
in aged care, and were strong deterrents to graduate and
younger doctors joining this aspect of medical practice.
The lack of support for LTCF activity from the next
generation of GPs meant that GPs currently servicing
LTCFs were overwhelmed with day-to-day responsibil-
ities, less likely to engage in time-consuming tasks such
as medication reviews and deprescribing decisions, and
generally preferring to maintain the status quo.
“I’d be very, very happy to give that [LTCF visits] to
anybody who wanted it, pay a significant amount of
money to get that off my hands. I’m completely burnt
out with it.” [GP; female, 47 years]
A need for realistic expectations There was some dis-
cordance between relatives’ and GPs’ perceptions of the
role of the LTCF in the care of the resident. Many rela-
tives viewed the LTCF as a 24 h medical care provider
with staff on hand at all times for the needs of the resi-
dent. GPs, however, stressed a need for the community
to accept the role of the LTCF as effectively a palliative
care environment, and for relatives to be more realistic
about the stage of life of their family member entering
into LTCF care.
“I think we really need to be in a situation where we’re
educating relatives about what is realistic because it’s
very hard to initiate the discussion with relatives.
Look, why are we treating, why are we on all of these
preventative medications when your relative is never
going to get better and they are going to get
progressively worse?” [GP; female 59 years]
Discussion
The RELEASE study is, to our knowledge, the first quali-
tative investigation of the perception of medication use
and deprescribing in LTCFs by those individuals directly
involved in the long-term care sector. While our findings
reiterate key themes of time, knowledge, fear and accept-
ance reported in studies of acceptance of medication re-
duction elsewhere [31, 35], importantly this research
emphasises the complexity of systems surrounding the
long-term care population in relation to medication
management: a cocktail of multiple healthcare providers,
hospital admissions, rigid organisational structures, re-
source limitations, medical hierarchies, contrasting care
expectations of family and GP and, amongst all of these,
the life priorities of each individual resident.
It is evident here that, with the exception of medica-
tion review pharmacists, our participating stakeholders
currently direct minimal attention to the identification
and reduction of PIMs for LTCF residents. This is des-
pite the ever increasing dialogue in the medical literature
about the risks of polypharmacy in older patients and a
need for deprescribing [15, 22, 35, 36], and helps explain
the lack of progress in this matter. For the resident and
their relatives, substantial trust in the advice and deci-
sions of the GP allows for their reduced self-efficacy and
general indifference about medication decisions. The in-
tegral role of the GP in this regard and their influence
on patients’ understanding of medication benefits and
acceptance of medication cessation has emerged in
studies previously [25, 31, 35, 37]. In Australian LTCFs,
where residents often have multiple specialist prescrib-
ing physicians, the role of the GP as the central coordin-
ating practitioner is even more vital. The additional
burden on the workload of GPs who provide aged care
services has been emphasized by GP advocacy groups
[38], with the non-contact time required to complete
LTCF patient-related communications and documenta-
tion noted as both a resourcing and financial disincen-
tive for GPs providing care for aged care residents.
System and resource related barriers to addressing
medication issues for LTCF residents reported here are
numerous, and for GPs these were a major deterrent to
committing to the processes and engagement required
for safe, rational medication reduction. The absence of a
standardised electronic medical records system used
across LTCFs, integrated with practice software, was
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highlighted as a significant hindrance to streamlined
medication management for GPs currently servicing
LTCFs and suggested as a deterrent to aged care work
for the next generation of GPs. Communication chal-
lenges were raised by all participants – a consequence of
the numerous stakeholders involved in the care of an
older person residing in aged care. Communication has
been previously highlighted as an enabler of successful
medication cessation in community-dwelling patients
[31, 37, 39–41]. The multiple layers of communication
in LTCFs provide complexity to an individual’s care deci-
sions and medication management: communication be-
tween resident and GP; between a resident’s various
medical specialists; between relatives, nursing staff, hos-
pital and GP; and between pharmacy and GP. The add-
itional step of needing to talk to a surrogate decision
maker for residents lacking mental competency make
these discussions even more difficult. Issues arising from
communication deficits have been previously linked to
medication errors during a resident’s transition into a
nursing home and following short-stay hospital admis-
sion [42].
Similar to findings of Spinewane et al. [43], participat-
ing GPs here expressed reluctance to interfere with med-
ications that had previously been prescribed by a
colleague or medical specialist. To some degree this was
a result of lack of confidence in deprescribing skills,
however an apparent fear of litigation, a perceived sense
of responsibility to a resident’s family to “keep the resi-
dent alive”, and averseness to the additional workload re-
quired to initiate and manage medication change were
also evident. Interestingly the value placed on a pharma-
cist’s recommendation for medication adjustments var-
ied across individual GPs and was influenced by the
length of working relationship between the two profes-
sionals. This finding supports previous studies which re-
port that GPs are more likely to accept a pharmacist’s
recommendations when there is personal rather than
written conveyance of review outcomes [44] and when
the review service is led by a pharmacist they know [45].
Hesitancy towards medication review and reduction
generated by lack of knowledge and practise was exhib-
ited across all stakeholders. Both residents and relatives
highlighted their difficulty in obtaining medicines infor-
mation from LTCF staff. Variability in the medication
skills of LTCF care staff was a source of frustration for
GP participants who believed it contributed to unneces-
sary communications from the LTCF and added to their
workload. Pharmacists commented on the important
role of LTCF staff in identifying and reporting potential
adverse drug events, and suggested a need for upskilling
in this area. Despite the availability of numerous tools to
guide PIM identification and processes for medication
cessation [17–22], GPs were largely unaware of standard
protocols for deprescribing. These findings give impetus
to the need for professional development on PIMs and
deprescribing for physicians providing direct medical
care for LTCF residents, as well as LTCF staff respon-
sible for general daily care and monitoring.
While we have mapped a variety of perceptions of
medication management, the conflicting views of rela-
tives and GPs regarding of the role of medications in
later life is perhaps one of the greatest attitudinal
challenges. Death constitutes the primary reason for
permanent LTCF resident separations each year (91 %
cases), and one-quarter of these deaths occur within
the first six months of admission [46]. GPs recognise
that in this late stage of life medical care is at least
partly palliative. In contrast, residents and their rela-
tives maintain conviction in the benefits of medica-
tions for both longevity and quality of life, and
relatives understandably struggle with the concept of
end-of-life care and the potential loss of a loved one.
Ensuring information about the goal of prescription
medicines for the frail elderly and the potential harms
of polypharmacy is available and accessible for residents
and their relatives is prerequisite to encouraging their ac-
tive involvement in shared decisions about medication
change. Insufficient knowledge of the role of medications
undoubtedly feeds fears of medication reduction and
cessation.
Limitations
This research was confined to aged care services in a
single region in New South Wales, Australia and
there are some limitations to the generalizability
of findings to LTCFs and nursing homes in other
settings. Although this study involved multiple stake-
holders, the recruitment of participants was via self-
selection and this may have resulted in a greater
representation of individuals with stronger pre-
existing attitudes towards medication use, particularly
amongst participating residents and relatives. Further,
barriers to the recruitment of GP participants limited
our GP numbers to a single GP focus group, which
(although rich in information) has consequences for
the adequacy of representation of the spectrum of age
and experience of GPs servicing LTCFs, as well as in-
formation saturation. Nevertheless, focus group dis-
cussions were conducted until we achieved saturation
across all other stakeholder groups, indicating that
the various themes were mostly well-explored and
contrasting views elicited. Finally, there was limited
cultural diversity across residents of participating
facilities and further investigation of attitudes and be-
liefs towards medication reduction held by specific
cultural groups and their health care providers is
warranted.
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Conclusions
Our data suggests that the lack of progress in depre-
scribing in the aged care sector is due to a complex mix
of reasons and therefore only a multi-faceted interven-
tion addressing the multiple barriers identified here is
likely to succeed. Such an intervention would need to
address the operational systems in LTCFs, institute
targeted engagement with residents and their support
network, and recognise that GPs are key to any depre-
scribing initiative. The current systems of medical record
keeping, communication and reimbursement in Austra-
lian long-term care are unfavourable to encouraging and
rewarding a GP’s active engagement in PIM reduction.
Deficits in knowledge and confidence of both LTCF
nursing staff and GPs providing aged care services
should be addressed to promote ongoing evaluation of a
resident’s clinical need for deprescribing and improve
self-efficacy in addressing PIM use. Without such efforts,
the necessary motivation to overcome the multiple bar-
riers to change may not be found.
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